Extended trial for kidney acidosis treatment halted before starting
NCT ID NCT03831152
Summary
This study aimed to check the long-term safety and effectiveness of a medication called ADV7103 for people with primary distal renal tubular acidosis (dRTA), a rare condition where the kidneys can't properly remove acid from the blood. It was designed for people who had been in a previous trial, as well as new patients, including infants. However, the study was withdrawn and never enrolled any participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACIDOSIS, RENAL TUBULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of South Florida Pediatric Infectious Diseases
Tampa, Florida, 33606, United States
Conditions
Explore the condition pages connected to this study.